Pre-emptive Paracetamol for Prevention of Intraoperative Shoulder Tip Pain
NCT ID: NCT04038307
Last Updated: 2020-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
120 participants
INTERVENTIONAL
2019-08-01
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preemptive Ketorolac for Shoulder Tip Pain During Cesarean Section
NCT02380898
Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain
NCT03878082
Preemptive Paracetamol for Postoperative Pain
NCT02425254
A Comparison of IV Versus PO Acetaminophen Postoperatively for Opioid Consumption After Cesarean Section
NCT04290208
RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief
NCT02046382
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
will receive 100 ml of saline
Saline Solution
100ml
paracetamol group
will receive 1gm paracetamol (100ml)
paracetamol
1gm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
paracetamol
1gm
Saline Solution
100ml
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* gestational diabetes
* cardiovascular or biliary disorders
* asthma
* renal impairment
* preeclampsia
* any chronic pain condition or trauma in the shoulder, forearms or upper limbs
* patients with any contraindication to SA were excluded from the study.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasmin Hassab elnaby
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS-12-2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.